Capstone Therapeutics Statistics Share Statistics Capstone Therapeutics has 5.41M
shares outstanding. The number of shares has increased by 9443.53%
in one year.
Shares Outstanding 5.41M Shares Change (YoY) 9443.53% Shares Change (QoQ) 268.73% Owned by Institutions (%) n/a Shares Floating 1.71M Failed to Deliver (FTD) Shares 3,652 FTD / Avg. Volume 0.2%
Short Selling Information The latest short interest is 45.56K, so 0.82% of the outstanding
shares have been sold short.
Short Interest 45.56K Short % of Shares Out 0.82% Short % of Float 2.3% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.14 and the forward
PE ratio is null.
Capstone Therapeutics's PEG ratio is
0.03.
PE Ratio -0.14 Forward PE n/a PS Ratio 0.01 Forward PS n/a PB Ratio -0.12 P/FCF Ratio 0.1 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Capstone Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.02,
with a Debt / Equity ratio of -5.43.
Current Ratio 1.02 Quick Ratio 0.27 Debt / Equity -5.43 Debt / EBITDA -137.29 Debt / FCF 4.49 Interest Coverage -0.43
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.25M Profits Per Employee $-71.19K Employee Count 36 Asset Turnover 0.95 Inventory Turnover 3.73
Taxes Income Tax -442K Effective Tax Rate 7.44%
Stock Price Statistics The stock price has increased by -74.22% in the
last 52 weeks. The beta is -0.81, so Capstone Therapeutics's
price volatility has been lower than the market average.
Beta -0.81 52-Week Price Change -74.22% 50-Day Moving Average 1.41 200-Day Moving Average 2.2 Relative Strength Index (RSI) 43.94 Average Volume (20 Days) 1,837,762
Income Statement In the last 12 months, Capstone Therapeutics had revenue of 44.88M
and earned -2.56M
in profits. Earnings per share was -34.86.
Revenue 44.88M Gross Profit 9.57M Operating Income -638K Net Income -2.56M EBITDA -121K EBIT -638K Earnings Per Share (EPS) -34.86
Full Income Statement Balance Sheet The company has 11K in cash and 16.61M in
debt, giving a net cash position of -16.6M.
Cash & Cash Equivalents 11K Total Debt 16.61M Net Cash -16.6M Retained Earnings -196.1M Total Assets 51.88M Working Capital -440K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 3.82M
and capital expenditures -120K, giving a free cash flow of 3.7M.
Operating Cash Flow 3.82M Capital Expenditures -120K Free Cash Flow 3.7M FCF Per Share 23.48
Full Cash Flow Statement Margins Gross margin is 21.33%, with operating and profit margins of -1.42% and -5.71%.
Gross Margin 21.33% Operating Margin -1.42% Pretax Margin -13.23% Profit Margin -5.71% EBITDA Margin -0.27% EBIT Margin -1.42% FCF Margin 8.25%
Dividends & Yields CAPS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CAPS.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 19, 2019. It was a
backward
split with a ratio of 1:1000.
Last Split Date Sep 19, 2019 Split Type backward Split Ratio 1:1000
Scores Altman Z-Score -4.21 Piotroski F-Score 5
